Want to join the conversation?
Mike Weinstein of JPMorgan asks about 670G timing. $MDT Diabetes Group President Hooman Hakami replied that the PMA is with the FDA and it's hard to predict when they are going to approve it. He added that the company is working actively with the FDA on the 670G approval.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.